Allspring Global Investments Holdings LLC Has $375,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Allspring Global Investments Holdings LLC reduced its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,473 shares of the company’s stock after selling 197 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Henry Schein were worth $375,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Versant Capital Management Inc grew its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Quent Capital LLC grew its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the period. City State Bank acquired a new stake in shares of Henry Schein in the 4th quarter valued at about $55,000. Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new stake in shares of Henry Schein in the 3rd quarter valued at about $109,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Price Performance

Henry Schein stock opened at $77.64 on Tuesday. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company’s 50 day moving average price is $74.19 and its two-hundred day moving average price is $72.38. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.68 billion, a P/E ratio of 31.95, a P/E/G ratio of 2.13 and a beta of 0.91.

Analysts Set New Price Targets

Several analysts have recently commented on HSIC shares. Mizuho started coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Barrington Research raised their target price on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Finally, Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Eight analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $80.09.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.